Skip to content

Clinical Feasibility of Full Free-Breathing Cardiac Magnetic Resonance Imaging

Full Free-Breathing Cardiac Magnetic Resonance Imaging: Clinical Feasibility, Efficiency, and Diagnostic Concordance

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07395843
Enrollment
605
Registered
2026-02-09
Start date
2024-11-12
Completion date
2025-12-20
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FAST Scan

Keywords

free-breathing, CMR, compressed sensing, motion correction

Brief summary

To evaluate the feasibility, efficiency, and diagnostic concordance of a full comprehensive free-breathing cardiac magnetic resonance protocol with motion correction and sensing.

Detailed description

This study aims to establish a large-scale, clinically oriented full free-breathing cardiac MRI framework to eliminate dependence on patient breath-holding, substantially shorten scan time, and improve patient comfort. Building on prior successful implementation of compressed sensing and motion correction techniques, the invesitgators will collaborate with the MRI vendor and sequence scientists to develop a comprehensive set of free-breathing sequences, including cine imaging, T1/T2 mapping, flow, perfusion, and late gadolinium enhancement (LGE). The study will then prospectively enroll a large, disease-diverse cohort of cardiovascular patients at Fuwai Hospital and systematically compare the full free-breathing protocol with conventional breath-hold protocols in terms of acquisition time, image quality, and agreement of quantitative parameters, thereby providing a comprehensive assessment of technical feasibility and clinical value.

Interventions

DIAGNOSTIC_TESTFree-breathing CMR

scan patients under free-breathing status

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* consecutive enrollment of patients referred for clinically indicated contrast-enhanced CMR

Exclusion criteria

* patients with CMR contraindications

Design outcomes

Primary

MeasureTime frameDescription
scan timeMeasurements are performed within 7 days after the completion of the CMR scan.total CMR examination time from the scanning time of first image to the last image

Secondary

MeasureTime frameDescription
image qualityMeasurements are performed within 7 days after the completion of the CMR scan.5-point Likert scale will be applied to assess image quality between two scanning methods, with a score of ≥3 considered clinically acceptable. Image quality was assessed visually using a 5-point Likert scale, defined as follows: 5 = excellent image quality; 4 = good quality with mild motion artifacts or distortion; 3 = presence of motion artifacts or distortion but sufficient image quality; 2 = fair quality with significant motion artifacts or distortion, limiting diagnostic utility; and 1 = non-diagnostic quality.
consistence of left ventricular ejection fractionMeasurements are performed within 7 days after the completion of the CMR scan.Linear regression and Bland-Altman analyses will be used to assess the correlation and agreement of left ventricular ejection fraction (%) from different techniques.
consistence of native T1 valuesMeasurements are performed within 7 days after the completion of the CMR scan.Linear regression and Bland-Altman analyses will be used to assess the correlation and agreement of native T1 values (ms) from different techniques.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026